Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-Fluciclovine PET/MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

NCT02562131 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT02562131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-Fluciclovine PET/MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2015
Completion date
December 31, 2027
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer recurrent